EKF Diagnostics Holdings plc (EKDHF)
OTCMKTS · Delayed Price · Currency is USD
0.3900
0.00 (0.00%)
At close: Aug 12, 2025
Market Cap164.46M
Revenue (ttm)62.84M
Net Income (ttm)7.81M
Shares Outn/a
EPS (ttm)0.02
PE Ratio21.05
Forward PE18.19
Dividendn/a
Ex-Dividend Daten/a
Volume20,000
Average Volume11,280
Open0.3900
Previous Closen/a
Day's Range0.3900 - 0.3900
52-Week Range0.2383 - 0.3900
Beta0.25
RSI46.10
Earnings DateSep 16, 2025

About EKF Diagnostics Holdings

EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm hand-held hemoglobin analyzer; Hemo Control, a hemoglobin and hematocrit analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. It also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Cl... [Read more]

Sector Healthcare
Founded 1990
Employees 303
Stock Exchange OTCMKTS
Ticker Symbol EKDHF
Full Company Profile

Financial Performance

In 2024, EKF Diagnostics Holdings's revenue was 50.19 million, a decrease of -4.59% compared to the previous year's 52.61 million. Earnings were 6.24 million, an increase of 165.39%.

Financial numbers in GBP Financial Statements

News

There is no news available yet.